Virology

TWiV 888: Molnupiravir with Richard Plemper

Richard joins TWiV to discuss the SARS-CoV-2 antiviral drug Molnupiravir , including how it was discovered, its mechanism of action, whether it is a mutagen for cells, and the future of drugs for treatment of COVID-19. Hosts: Vincent Racaniello, Alan Dove, and Brianne Barker Guest: Richard Plemper Click arrow to playDownload TWiV ...

Q&A with A&V Livestream 4/13/22

Virologists Amy Rosenfeld and Vincent Racaniello answer your COVID-19 questions (or any virus questions) on this livestream of 4/13/22 at 8:30 PM eastern US.

TWiV 887: Bonfire of the monocytes

TWiV explains why this season's influenza vaccine is not protecting against mild to moderate disease caused by H3N2 virus, and that antibody-dependent entry of SARS-CoV-2 into monocytes is a major contributor to severe COVID-19. Hosts: Vincent Racaniello, Dickson Despommier, Rich Condit, and Amy Rosenfeld Click arrow to playDownload TWiV 887 (65 MB ...

TWiV 886: COVID-19 clinical update #109 with Dr. Daniel Griffin

In COVID-19 clinical update #109, Daniel Griffin discusses cardiac complications after infection or vaccination, long COVID in children, fourth vaccine dose in Israel, no need for fourth vaccine dose in EU, dexamethasone dosing, immunomodulation therapy, MIS outcomes in children, US long COVID effort launched, and herd immunity. Click arrow to ...

A Viral Risk Factor for Multiple Sclerosis

by Gertrud U. Rey Epstein-Barr virus (EBV) is a prevalent human herpesvirus that is most commonly transmitted through saliva and is well known for causing infectious mononucleosis (i.e., “mono”). Various recent lines of evidence suggest that EBV infection may also be a risk factor for the development of multiple sclerosis ...
Scroll to Top